Filter
282
Text search:
in
vitro
Featured
Recommendations
30
New Publications
38
Language
Document type
No document type
103
Guidelines
91
Studies & Reports
40
Manuals
23
Strategic & Response Plan
10
Fact sheets
9
Training Material
2
Situation Updates
2
Resource Platforms
2
Countries / Regions
Russia
12
South Africa
9
Global
7
India
6
Germany
6
Brazil
5
Latin America and the Carribbean
5
Uganda
4
Kenya
4
Paraguay
4
Africa
4
Western and Central Europe
3
Venezuela
3
Sierra Leone
2
Nigeria
2
Ethiopia
2
Zambia
2
Rwanda
2
Colombia
2
Bolivia
2
East and Southern Africa
2
West and Central Africa
2
Eastern Europe
2
Burkina Faso
1
Liberia
1
Congo, Democratic Republic of
1
Cameroon
1
Zimbabwe
1
Philippines
1
Tanzania
1
Indonesia
1
Bangladesh
1
Namibia
1
Peru
1
Eswatini/ Swaziland
1
Ukraine
1
El Salvador
1
Guatemala
1
Myanmar / Burma
1
Middle East and North Africa
1
Albania
1
Kazakhstan
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
74
Clinical Guidelines
50
Pharmacy & Technologies
15
Women & Child Health
13
Key Resources
7
Public Health
6
Toolboxes
TB
42
COVID-19
42
HIV
35
NTDs
23
AMR
21
Ebola & Marburg
9
Pharmacy
9
Caregiver
6
Rapid Response
5
Refugee
5
Zika
5
Planetary Health
5
Malaria
5
Mental Health
3
Specific Hazards
3
Polio
2
Natural Hazards
2
NCDs
2
Conflict
1
Social Ethics
1
2.0 Rapid Response
1
The Guidance on global monitoring for diabetes prevention and control by WHO provides a comprehensive framework to support countries in tracking and managing diabetes prevention, care, and outcomes. This document outlines indicators across 4 domains
...
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in
...
Human African trypanosomiasis (HAT), or sleeping sickness, is an endemic disease in 36 sub-Saharan African countries, typically occurring in underdeveloped areas, where
health systems face signifi
...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
...
This pocket guide offers basic information needed for the medical management of victims of radiation incidents in an easy-to-understand manner.
Über SARS-CoV-2-Testsysteme informieren das Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) und das Paul-Ehrlich-Institut. Die Informationen ergänzen sich, den rechtlichen Rahmen bietet u.a. die Coronavirus-Testverordnung-TestV.
Das BfArM bietet eine Liste von Antigen-Tests zum dir
...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms.
...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID
...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas
...
GDF is the largest global provider of quality-assured tuberculosis (TB)
medicines, diagnostics, and laboratory supplies to the public sector.
Since 2001, GDF has facilitated access to high-quality TB care in over 130
countries, providing treatmen
...
HIV testing programmes need to ensure that all clients who test for HIV are provided with correct diagnoses. The accuracy of HIV testing is critical to prevent misdiagnosis, as the consequences of giving an incorrect test result can be serious for clients, HIV testing services, HIV programmes and pu
...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
th
...
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight
...
The intent of these guidelines is to develop a holistic, coordinated, proactive and technology driven strategy for management of biological disasters through a culture of prevention, mitigation and preparedness to generate a prompt and effective response
...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f
...
Chromoblastomycosis (CMB) is a chronic fungal infection of the skin and the subcutaneous tissue caused by a transcutaneous traumatic inoculation of a specific group of dematiaceous fungi occurring mainly in tropical and subtropical zones worldwide.
...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries
...
This guideline provides evidence-informed guidance on the use of non-sugar sweeteners to reduce the risk of unhealthy weight gain and diet-related noncommunicable diseases in adults and children. The guidance
...
The Ministry of Health together with its partners realizes that efficient and effective
delivery of clinical care is highly dependent on the availability of appropriately
upgraded environment, which is in well facilitated space. Such facilities an
...
